Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 20;16(1):9.
doi: 10.1186/s13099-024-00604-0.

16S rRNA sequencing analysis of the oral and fecal microbiota in colorectal cancer positives versus colorectal cancer negatives in Iranian population

Affiliations

16S rRNA sequencing analysis of the oral and fecal microbiota in colorectal cancer positives versus colorectal cancer negatives in Iranian population

Sama Rezasoltani et al. Gut Pathog. .

Erratum in

Abstract

Background: Colorectal cancer (CRC) poses a significant healthcare challenge, accounting for nearly 6.1% of global cancer cases. Early detection, facilitated by population screening utilizing innovative biomarkers, is pivotal for mitigating CRC incidence. This study aims to scrutinize the fecal and salivary microbiomes of CRC-positive individuals (CPs) in comparison to CRC-negative counterparts (CNs) to enhance early CRC diagnosis through microbial biomarkers.

Material and methods: A total of 80 oral and stool samples were collected from Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, encompassing both CPs and CNs undergoing screening. Microbial profiling was conducted using 16S rRNA sequencing assays, employing the Nextera XT Index Kit on an Illumina NovaSeq platform.

Results: Distinct microbial profiles were observed in saliva and stool samples of CPs, diverging significantly from those of CNs at various taxonomic levels, including phylum, family, and species. Saliva samples from CPs exhibited abundance of Calothrix parietina, Granulicatella adiacens, Rothia dentocariosa, and Rothia mucilaginosa, absent in CNs. Additionally, Lachnospiraceae and Prevotellaceae were markedly higher in CPs' feces, while the Fusobacteria phylum was significantly elevated in CPs' saliva. Conversely, the non-pathogenic bacterium Akkermansia muciniphila exhibited a significant decrease in CPs' fecal samples compared to CNs.

Conclusion: Through meticulous selection of saliva and stool microbes based on Mean Decrease GINI values and employing logistic regression for saliva and support vector machine models for stool, we successfully developed a microbiota test with heightened sensitivity and specificity for early CRC detection.

Keywords: 16S rRNA sequencing; Colorectal cancer; Early detection; Fecal microbiota; Oral microbiota.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests.

Figures

Fig. 1
Fig. 1
The frequency of top 10 bacteria that were most abundant in oral and fecal samples of colorectal cancer positives (CPs) for phylum, family, and species versus colorectal cancer negatives (CNs) [# = CRC-exclusive bacteria, * = significant CRC vs. normal differences]
Fig. 2
Fig. 2
The higher abundancy of the genus Akkermansia and the species Akkermansia muciniphila among all the non-pathogenic microbes in the stool samples of colorectal cancer negatives versus colorectal cancer positive patients
Fig. 3
Fig. 3
Mean Decrease GINI model for colorectal cancer prediction. Higher mean decreases in GINI for bacteria show that bacteria are more important in predicting CRC. *The Mean Decrease GINI presents those microbes that have the highest amount in GINI, their removal makes the model worse in the direction of predicting CRC and their presence helps the model to be powerful
Fig. 4
Fig. 4
ROC curves with performance of logistic model, support vector machine, naïve bayes and neural network models using selected variables

References

    1. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Przeglad Gastroenterol. 2019;14(2):89–103. - PMC - PubMed
    1. Roselló S, Simón S, Cervantes A. Programmed colorectal cancer screening decreases incidence and mortality. Transl Gastroenterol Hepatol. 2019;4:84. doi: 10.21037/tgh.2019.12.13. - DOI - PMC - PubMed
    1. Zhang J, Chen G, Li Z, Zhang P, Li X, Gan D, et al. Colonoscopic screening is associated with reduced Colorectal Cancer incidence and mortality: a systematic review and meta-analysis. J Cancer. 2020;11(20):5953–5970. doi: 10.7150/jca.46661. - DOI - PMC - PubMed
    1. Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, et al. Colorectal cancer screening: recommendations for physicians and patients from the US multi-society task force on colorectal cancer. Am J Gastroenterol. 2017;112(7):1016–1030. doi: 10.1038/ajg.2017.174. - DOI - PubMed
    1. Quintero E, Hassan C, Senore C, Saito Y. Progress and challenges in colorectal cancer screening. Gastroenterol Res Pract. 2012;2012:846985. - PMC - PubMed

LinkOut - more resources